Compassionate use of and expanded access to new drugs for drug-resistant tuberculosis [Review article]
Document Type: Research Article
Affiliations: 1: Department of Epidemiology, Boston University School of Public Health, Boston, Massachusetts, USA 2: Tibotec, Turnhout, Belgium 3: Stop TB Department, World Health Organization, Geneva, Switzerland 4: PATH, Washington DC, USA 5: Medical Service Corporation International, Arlington, Virginia, USA 6: HIV/TB Division, Bill & Melinda Gates Foundation, Seattle, Washington, USA 7: Partners in Health, Boston, Massachusetts, USA 8: Médecins Sans Frontières, Paris, France
Publication date: February 1, 2013
The International Journal of Tuberculosis and Lung Disease publishes articles on all aspects of lung health, including public health-related issues such as training programmes, cost-benefit analysis, legislation, epidemiology, intervention studies and health systems research. The IJTLD is dedicated to the continuing education of physicians and health personnel and the dissemination of information on lung health world-wide.
To share scientific research of immediate concern as rapidly as possible, The Union is fast-tracking the publication of certain articles from the IJTLD and publishing them on The Union website, prior to their publication in the Journal. Read fast-track articles.
Certain IJTLD articles are also selected for translation into French, Spanish, Chinese or Russian. These are available on the Union website.
- Editorial Board
- Information for Authors
- Subscribe to this Title
- International Journal of Tuberculosis and Lung Disease
- Public Health Action
- Ingenta Connect is not responsible for the content or availability of external websites